INJEKTORVORRICHTUNG
European patent · EP3538184 · In force
Register entry
- Publication number
- EP3538184
- Application number
- EP17783845
- Kind
- European patent with effect for Switzerland and Liechtenstein
- Status
- In force
- Specification
- Granted
- Filed
- Oct 12, 2017
- Published
- Sep 18, 2019
- Granted
- Jul 23, 2025
- Protection ends at the latest
- Oct 11, 2037
- Next annual fee due
- Oct 31, 2027
- IPC classes
- A61M 5/315 (2006.01)A61M 5/20 (2006.01)
- Priority
- EP 16197955 09.11.2016
- PCT application
- PCT/EP2017/076108 12.10.2017
- PCT publication
- WO2018/086817 17.05.2018
- Filing language
- English
- Source
- Swissreg
History
What the Federal Institute of Intellectual Property published about this title, newest first.
- Nov 1, 2026
Next annual fee due on
- Next annual fee due on
- 31.10.2026 → 31.10.2027
Published in Swissreg on 01.11.2026
- Jun 4, 2026
Change
Published in Swissreg on 04.06.2026
- Dec 22, 2025
Holder’s address changed
- Owner
- Sanofi-Aventis Deutschland GmbH, Brüningstraße 50, Bldg. K703, Room 4071, 65926 Frankfurt am Main, Germany → Sanofi-Aventis Deutschland GmbH, Brüningstraße 50, 65929 Frankfurt am Main, Germany
Published in Swissreg on 22.12.2025
- Nov 1, 2025
Next annual fee due on
- Next annual fee due on
- 31.10.2025 → 31.10.2026
Published in Swissreg on 01.11.2025
- Jul 23, 2025
Granted
- Specification status
- Non-published patent application → Granted patent
- Status of protective title
- Initiated → Active
Published in Swissreg on 23.07.2025
Parties
Inventor
WILSON, Robbie
Melbourn Hertfordshire SG5 6DP, GB
SINGH, Harpal
Melbourn Hertfordshire SG5 6DP, GB
YOUNG, Matthew
Melbourn Hertfordshire SG5 6DP, GB
The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.